Arteriosclerosis
Not yet recruitingStudy of Olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)
- Disease:Arteriosclerosis
- Substances:–
Belgium- Participants:18–64 years · 65+ years
- Sponsor:Amgen Inc.
Rare diseases
Investigational molecules
Locations
Back to Belgium177 clinical trials in Hasselt, Belgium across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
BelgiumThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking studies focusing on non-small cell lung cancer treatments and novel therapeutic approaches for various stages of breast cancer. Multiple trials are evaluating innovative combination therapies and targeted treatments.
Research emphasizes personalized treatment approaches and immunotherapy combinations.
Innovative research examining heart failure treatments and surgical interventions. Studies focus on preventing complications during open-heart surgery and managing various cardiac conditions.
Trials aim to improve patient outcomes and develop safer surgical procedures.
Studies exploring SARS-CoV-2 immunity in vulnerable populations and investigating treatments for various infections. Research includes both preventive measures and therapeutic interventions.
Focus on long-term immunity monitoring and novel therapeutic approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.